Display options
Cite
Chouaieb E, Terry S, Corgnac S, et al. Cancer Immunotherapy 2017 (Paris, France). Progress and challenges. Bull Cancer. 2018;105(5):537-541doi: 10.1016/j.bulcan.2018.02.006.
Chouaieb, E., Terry, S., Corgnac, S., & Engelsen, A. S. T. (2018). Cancer Immunotherapy 2017 (Paris, France). Progress and challenges. Bulletin du cancer, 105(5), 537-541. https://doi.org/10.1016/j.bulcan.2018.02.006
Chouaieb, Elyes, et al. "Cancer Immunotherapy 2017 (Paris, France). Progress and challenges." Bulletin du cancer vol. 105,5 (2018): 537-541. doi: https://doi.org/10.1016/j.bulcan.2018.02.006
Chouaieb E, Terry S, Corgnac S, Engelsen AST. Cancer Immunotherapy 2017 (Paris, France). Progress and challenges. Bull Cancer. 2018 May;105(5):537-541. doi: 10.1016/j.bulcan.2018.02.006. Epub 2018 Apr 12. PMID: 29656785.
Copy Download .nbib Format: NLM
Share it on

Bull Cancer. 2018 May;105(5):537-541. doi: 10.1016/j.bulcan.2018.02.006. Epub 2018 Apr 12.

Cancer Immunotherapy 2017 (Paris, France). Progress and challenges.

Bulletin du cancer

Elyes Chouaieb, Stéphane Terry, Stéphanie Corgnac, Agnete Svendsen Tenfjord Engelsen

Affiliations

  1. Université Paris Sud, faculté de pharmacie, 5, rue Jean-Baptiste-Clément, 92290 Châtenay-Malabry, France.
  2. Université Paris-Sud, université Paris-Saclay, faculté de médecine, Integrative Tumor Immunology and Genetic Oncology, Inserm UMR 1186, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif, France.
  3. Université Paris-Sud, université Paris-Saclay, faculté de médecine, Integrative Tumor Immunology and Genetic Oncology, Inserm UMR 1186, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif, France; University of Bergen, Centre for Cancer Biomarkers (CCBIO), Department of Biomedicine, Jonas Lies vei 91, 5009 Bergen, Norway. Electronic address: [email protected].

PMID: 29656785 DOI: 10.1016/j.bulcan.2018.02.006

[No abstract available.]

Publication Types